KVYO.NYSEKlaviyo, INC

Form 4: Klaviyo Insider Sells 200,000 Shares

Sentiment:

Insider Transaction Report


Klaviyo Co-CEO Andrew Bialecki sold 200,000 shares of Series A Common Stock for approximately $19.42 per share, totaling $3.88 million, as part of a pre-arranged trading plan.

Summary

  • Andrew Bialecki, Co-Chief Executive Officer, Director, and 10% owner of Klaviyo, Inc., reported the sale of 200,000 shares of Series A Common Stock.
  • The transactions occurred on March 31, 2026, and were executed under a Rule 10b5-1 trading plan adopted on May 20, 2025.
  • The sale generated approximately $3.88 million, with shares sold at a weighted average price of $19.42, ranging from $18.85 to $19.75.
  • Following these transactions, Bialecki directly beneficially owns 0 shares of Series A Common Stock.
  • However, Bialecki indirectly beneficially owns a significant number of shares through various trusts, including the Andrew P. Bialecki Grantor Retained Annuity Trust I of 2023, the Elizabeth L. Bialecki Irrevocable GST Trust of 2023, and the Andrew P. Bialecki Irrevocable GST Trust of 2023, as well as shares held by his spouse.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a slightly negative development due to the significant sale by a top executive, despite being executed under a 10b5-1 plan.

Negatives

  • A significant number of shares (200,000) were sold by a key executive, potentially signaling a lack of confidence or a need for personal liquidity.

Risks

  • The sale of a substantial number of shares by a Co-CEO could be interpreted negatively by the market, potentially impacting investor sentiment.
  • The Rule 10b5-1 trading plan, while providing a defense against insider trading allegations, still represents a divestment of company stock by a top executive.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. It solely reports on past transactions.

Industry Context

StockSavvy.ai notes that insider selling, especially by C-suite executives, is a common event and often executed under pre-arranged 10b5-1 plans to diversify or meet personal financial needs. However, the volume and timing relative to company performance can influence market perception.

Stakeholder Impact

  • Shareholders: May view the sale as a negative signal, potentially impacting share price in the short term.
  • Employees: May be concerned about executive confidence in the company's future prospects.
  • Management: The sale is executed under a plan designed to comply with regulations, but the volume could still raise questions about personal financial priorities.

Next Steps

  • Monitor future insider trading activity for any further sales or purchases.
  • Analyze Klaviyo's upcoming financial reports and strategic announcements for context regarding executive compensation and liquidity needs.

Key Dates

DateDescription
05/20/2025Date Rule 10b5-1 trading plan was adopted by the Reporting Person.
03/31/2026Date of transactions (sale of Series A Common Stock).
04/02/2026Date of filing of the Form 4.

Recommendation

hold

The sale by a key executive, while notable, was conducted under a pre-arranged 10b5-1 plan, mitigating immediate concerns of opportunistic selling. The filing itself does not provide performance data or future guidance to warrant a strong buy or sell. Therefore, a 'hold' recommendation is appropriate pending further company disclosures and market analysis.

Keywords

Klaviyo, KVYO, Insider Trading, Stock Sale, Rule 10b5-1, Andrew Bialecki, Series A Common Stock, Beneficial Ownership, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.